Novartis India Limited (NSE:NOVARTIND)
India flag India · Delayed Price · Currency is INR
2,005.20
-22.20 (-1.10%)
Sep 24, 2026, 11:10 AM IST

Novartis India Company Description

Novartis India Limited is involved in the pharmaceutical business in India.

The company offers therapeutic products in the areas of bone and pain under the Voveran brand; transplantation immunology under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands.

It also offers neuroscience products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is headquartered in Mumbai, India.

As of July 29, 2026, Novartis India Limited operates as a subsidiary of Waverise Investments Limited.

Novartis India Limited
CountryIndia
Founded1947
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees57
CEOVikas Gupta

Contact Details

Address:
Inspire BKC
Mumbai, 400051
India
Phone91 22 50243000
Websitenovartis.in

Stock Details

Ticker SymbolNOVARTIND
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE234A01025
SIC Code2834

Key Executives

NamePosition
Dr. Vasant NarasimhanChief Executive Officer of Novartis
Sanjay Prabhakar MurdeshwarMD and Vice Chairman
Shilpa JoshiChief Financial Officer and Whole-Time Director
Nikhil MalpaniCompany Secretary and Compliance Officer
N. KumarCountry Head of Ethics, Risk and Compliance